Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
microMend® logo — Designed to replace sutures and staples, microMend PRO devic...

microMend®

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare professionals

Founded 2011 United States Seattle, United States 11 employees Series B Total: $15.93M Biotechnology, Health Care +2

General Information

Company Name microMend®
Founded Year 2011
Location United States Seattle, United States +1
Employees 11
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series B
Social

Get notified when microMend® moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About microMend®

microMend® by KitoTech Medical is a Seattle-based biotechnology startup that offers a groundbreaking wound closure solution. The microMend PRO devices are designed to replace sutures and staples, catering to healthcare professionals as an ideal alternative. With a founding year of 2011, this innovative product has garnered attention in the healthcare, biotechnology, and manufacturing industries. The recent $2.00M Series B investment from Keiretsu Capital in December 2021 has significantly boosted the company's growth. microMend PRO effectively closes wounds up to 50 cm in length and has proven successful for various laceration types, including those with jagged edges. Its efficacy, combined with ease of application, has led to superior clinical results and improved patient experiences, ultimately leading to reduced procedure costs. The startup's emphasis on addressing unmet clinical needs indicates promising scalability in the healthcare market. Overall, microMend PRO's disruptive technology, coupled with strategic investments, positions the company for continued success in the medical device domain.

Taxonomy: medical device, wound closure, suturing alternative, clinical effectiveness, patient experience, surgical equipment, dermatology, emergency medicine, surgical procedures, medical device company, wound care, surgical tools, cost-effective healthcare solutions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
06 Dec 2021
Convertible Note •••••• - 10 Mar 2021
Convertible Note •••••• 3
Investor Investor
•••• •••• 		01 Aug 2020
Convertible Note •••••• - 22 Nov 2019
Convertible Note •••••• - 07 Feb 2019

View All 7 Funding Rounds

microMend® Alternatives & Competitors

microMend® vs
Starling Surgical
Starling Surgical Ireland

The only wound closure device, as fast as a skin stapler, with all the clinical advantages of meticu...

Seed
1 employees
Health Care
microMend® vs
SweetBio, Inc.
SweetBio, Inc. United States

Simplifying your journey to closure with our collagen + honey advanced wound care products. #woundca...

Unknown
11 employees
Biotechnology, Health Care
microMend® vs
DermaClip US, LLC
DermaClip US, LLC United States

A new wound closure paradigm. The DermaClip non-invasive device replaces sutures, staples and glues...

5 employees

FAQ About microMend®

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare professionals
microMend® was founded in 2011.
microMend® is headquartered in Seattle, United States.
microMend® operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.
microMend® has approximately 11 employees.
microMend® has completed 7 funding rounds, raising a total of $15.93M. The latest funding stage is Series B.
Top alternatives and competitors to microMend® include Starling Surgical, SweetBio, Inc., DermaClip US, LLC, CP Medical, Inc., RedDress Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
microMend® and Starling Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors microMend® and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy